Clinical Trial Update: Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating alloreactive NK cells as an adjunct to allogeneic stem cell transplantation in patients with myelodysplastic syndrome and acute myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Alloreactive natural killer (NK) cells for allogeneic stem cell transplantation (alloreactive natural killer cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Leukemia | Phase 1 | Status: COMPLETED